Tauseef R. Butt, PhD

Tauseef Butt received his PhD degree in Molecular Biology from The University of Glasgow, Scotland. He was a Staff Fellow at the National Institutes of Health, Bethesda, MD, before joining SmithKline (now GSK) Pharmaceuticals. He serves as President and CEO of Progenra. He was an Adjunct Professors in Biochemistry and Biophysics, at University of Pennsylvania Medical School, Philadelphia PA. He is also an Adjunct Professor in Biomedical Engineering at Drexel University, Philadelphia. He has been instrumental in raising ~$175 million capital.